Rallybio Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Rallybio Corp.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Rallybio Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Rallybio Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Rallybio Corp. is RLYB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Rallybio Corp. has its primary listing on NASDAQ. You can trade Rallybio Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Rallybio Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Rallybio Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Rallybio Corp..